Alpine Immune Sciences Ownership 2024 | Who Owns Alpine Immune Sciences Now?
Institutional Ownership
28.32%
Insider Ownership
4.65%
Retail Ownership
67.03%
Institutional Holders
84.00
Alpine Immune Sciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | 16.64% | 44.22% | 8,317,924 | 1,234,636 | 17.43% | 329,722,507 | Mar 31, 2024 |
| AVORO CAPITAL ADVISORS LLC | 11.55% | 2.67% | 5,775,000 | 5,775,000 | 100.00% | 228,921,000 | Mar 31, 2024 |
| BLACKROCK INC. | 7.15% | 0.00% | 3,575,092 | 516,594 | 16.89% | 141,716,649 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 6.26% | 5.24% | 3,131,008 | - | - | 124,113,157 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.16% | 0.01% | 3,080,220 | 1,392,942 | 82.56% | 122,101,000 | Mar 31, 2024 |
| STATE STREET CORP | 5.69% | 0.01% | 2,845,839 | 1,455,810 | 104.73% | 112,809,058 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.42% | 0.00% | 2,712,285 | 477,518 | 21.37% | 107,514,978 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 5.40% | 4.69% | 2,700,000 | 150,000 | 5.88% | 107,028,000 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 5.36% | 1.96% | 2,680,496 | 145,251 | 5.73% | 106,254,861 | Mar 31, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 4.51% | 23.15% | 2,253,183 | -1,560,743 | -40.92% | 89,316,174 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 4.24% | 2.96% | 2,121,163 | -1,055,580 | -33.23% | 84,082,901 | Mar 31, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 3.96% | 10.46% | 1,982,016 | 1,982,016 | 100.00% | 78,567,114 | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 2.75% | 3.64% | 1,375,000 | -235,000 | -14.60% | 54,505,000 | Mar 31, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 2.48% | 5.90% | 1,241,300 | - | - | 49,205,132 | Mar 31, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 2.35% | 1.50% | 1,174,700 | 1,174,700 | 100.00% | 46,565,108 | Mar 31, 2024 |
| GREAT POINT PARTNERS LLC | 2.26% | 6.97% | 1,128,499 | -2,574,934 | -69.53% | 44,733,700 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 2.19% | 0.01% | 1,093,203 | -127,130 | -10.42% | 43,334,567 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.82% | 0.00% | 910,599 | 146,252 | 19.13% | 36,101,428 | Mar 31, 2024 |
| MORGAN STANLEY | 1.58% | 0.00% | 789,645 | 70,904 | 9.87% | 31,301,528 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 1.34% | 0.06% | 668,775 | 404,700 | 153.25% | 26,510,241 | Mar 31, 2024 |
Alpine Immune Sciences's largest institutional shareholder is DECHENG CAPITAL LLC, holding 16.64% of the company's total share outstanding, currently valued at $329.72M. The top 10 institutional shareholders own together 74.14% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | 16.64% | 44.22% | 8,317,924 | 1,234,636 | 17.43% | 329,722,507 | Mar 31, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 4.51% | 23.15% | 2,253,183 | -1,560,743 | -40.92% | 89,316,174 | Mar 31, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 3.96% | 10.46% | 1,982,016 | 1,982,016 | 100.00% | 78,567,114 | Mar 31, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.53% | 9.69% | 263,940 | - | - | 10,462,582 | Mar 31, 2024 |
| GREAT POINT PARTNERS LLC | 2.26% | 6.97% | 1,128,499 | -2,574,934 | -69.53% | 44,733,700 | Mar 31, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 2.48% | 5.90% | 1,241,300 | - | - | 49,205,132 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 6.26% | 5.24% | 3,131,008 | - | - | 124,113,157 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 5.40% | 4.69% | 2,700,000 | 150,000 | 5.88% | 107,028,000 | Mar 31, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.23% | 3.97% | 117,000 | -56,500 | -32.56% | 4,637,880 | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 2.75% | 3.64% | 1,375,000 | -235,000 | -14.60% | 54,505,000 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 4.24% | 2.96% | 2,121,163 | -1,055,580 | -33.23% | 84,082,901 | Mar 31, 2024 |
| AVORO CAPITAL ADVISORS LLC | 11.55% | 2.67% | 5,775,000 | 5,775,000 | 100.00% | 228,921,000 | Mar 31, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.40% | 2.19% | 199,020 | -98,769 | -33.17% | 7,889,153 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 5.36% | 1.96% | 2,680,496 | 145,251 | 5.73% | 106,254,861 | Mar 31, 2024 |
| TRI LOCUM PARTNERS LP | 0.24% | 1.66% | 120,687 | 120,687 | 100.00% | 4,784,033 | Mar 31, 2024 |
| VIVO CAPITAL, LLC | 1.04% | 1.63% | 520,505 | -298,770 | -36.47% | 20,794,175 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.00% | 1.52% | 501,243 | 501,243 | 100.00% | 19,869,273 | Mar 31, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 2.35% | 1.50% | 1,174,700 | 1,174,700 | 100.00% | 46,565,108 | Mar 31, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.16% | 1.22% | 77,848 | -875 | -1.11% | 3,085,895 | Mar 31, 2024 |
| VESTAL POINT CAPITAL, LP | 0.70% | 1.15% | 350,000 | 350,000 | 100.00% | 13,874,000 | Mar 31, 2024 |
The largest Alpine Immune Sciences shareholder by % of total assets is DECHENG CAPITAL LLC. The company owns 8.32M shares of Alpine Immune Sciences (ALPN), representing 44.22% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 11.55% | 2.67% | 5,775,000 | 5,775,000 | 100.00% | 228,921,000 | Mar 31, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 3.96% | 10.46% | 1,982,016 | 1,982,016 | 100.00% | 78,567,114 | Mar 31, 2024 |
| STATE STREET CORP | 5.69% | 0.01% | 2,845,839 | 1,455,810 | 104.73% | 112,809,058 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.16% | 0.01% | 3,080,220 | 1,392,942 | 82.56% | 122,101,000 | Mar 31, 2024 |
| DECHENG CAPITAL LLC | 16.64% | 44.22% | 8,317,924 | 1,234,636 | 17.43% | 329,722,507 | Mar 31, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 2.35% | 1.50% | 1,174,700 | 1,174,700 | 100.00% | 46,565,108 | Mar 31, 2024 |
| BLACKROCK INC. | 7.15% | 0.00% | 3,575,092 | 516,594 | 16.89% | 141,716,649 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.00% | 1.52% | 501,243 | 501,243 | 100.00% | 19,869,273 | Mar 31, 2024 |
| VANGUARD GROUP INC | 5.42% | 0.00% | 2,712,285 | 477,518 | 21.37% | 107,514,978 | Mar 31, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.82% | 0.25% | 408,542 | 408,542 | 100.00% | 16,194,605 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 1.34% | 0.06% | 668,775 | 404,700 | 153.25% | 26,510,241 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.03% | 0.01% | 513,175 | 383,209 | 294.85% | 20,342,257 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.75% | 0.03% | 372,995 | 372,995 | 100.00% | 14,785,522 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 0.81% | 0.41% | 405,784 | 355,025 | 699.43% | 16,085,278 | Mar 31, 2024 |
| VESTAL POINT CAPITAL, LP | 0.70% | 1.15% | 350,000 | 350,000 | 100.00% | 13,874,000 | Mar 31, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | 0.51% | 1.00% | 256,000 | 256,000 | 100.00% | 10,147,840 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.46% | 0.85% | 230,000 | 230,000 | 100.00% | 9,117,200 | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.65% | 0.00% | 325,943 | 223,591 | 218.45% | 12,920,377 | Mar 31, 2024 |
| CITIGROUP INC | 0.41% | 0.01% | 207,496 | 171,719 | 479.97% | 8,225,141 | Mar 31, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.47% | 0.03% | 234,625 | 154,463 | 192.69% | 9,300,535 | Mar 31, 2024 |
As of Mar 31 2024, Alpine Immune Sciences's largest institutional buyer is AVORO CAPITAL ADVISORS LLC. The company purchased 5.78M stocks of ALPN, valued at $228.92M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -4,909,763 | -100.00% | - | Mar 31, 2024 |
| GREAT POINT PARTNERS LLC | 2.26% | 6.97% | 1,128,499 | -2,574,934 | -69.53% | 44,733,700 | Mar 31, 2024 |
| LYNX1 CAPITAL MANAGEMENT LP | 4.51% | 23.15% | 2,253,183 | -1,560,743 | -40.92% | 89,316,174 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 4.24% | 2.96% | 2,121,163 | -1,055,580 | -33.23% | 84,082,901 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | 0.51% | 0.09% | 254,334 | -745,772 | -74.57% | 10,081,800 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.29% | 0.00% | 142,879 | -732,378 | -83.68% | 5,663,724 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.62% | 0.02% | 310,000 | -404,590 | -56.62% | 12,288,400 | Mar 31, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -357,271 | -100.00% | - | Mar 31, 2024 |
| VIVO CAPITAL, LLC | 1.04% | 1.63% | 520,505 | -298,770 | -36.47% | 20,794,175 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.03% | 0.00% | 14,438 | -258,628 | -94.71% | 572,322 | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -246,178 | -100.00% | - | Mar 31, 2024 |
| COMMODORE CAPITAL LP | 2.75% | 3.64% | 1,375,000 | -235,000 | -14.60% | 54,505,000 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.52% | 1.13% | 261,365 | -225,883 | -46.36% | 10,360,508 | Mar 31, 2024 |
| MARSHALL WACE, LLP | - | - | - | -221,118 | -100.00% | - | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -197,019 | -100.00% | - | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.09% | 0.25% | 44,841 | -190,000 | -80.91% | 1,777,497 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.41% | 0.01% | 206,104 | -159,836 | -43.68% | 8,169,963 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 0.90% | 0.01% | 450,827 | -132,412 | -22.70% | 17,839,239 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 2.19% | 0.01% | 1,093,203 | -127,130 | -10.42% | 43,334,567 | Mar 31, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.40% | 2.19% | 199,020 | -98,769 | -33.17% | 7,889,153 | Mar 31, 2024 |
As of Mar 31 2024, Alpine Immune Sciences's biggest institutional seller is RA CAPITAL MANAGEMENT, L.P.. The company sold -4.91M shares of ALPN, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 11.55% | 2.67% | 5,775,000 | 5,775,000 | 100.00% | 228,921,000 | Mar 31, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 3.96% | 10.46% | 1,982,016 | 1,982,016 | 100.00% | 78,567,114 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.00% | 1.52% | 501,243 | 501,243 | 100.00% | 19,869,273 | Mar 31, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | 0.82% | 0.25% | 408,542 | 408,542 | 100.00% | 16,194,605 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.75% | 0.03% | 372,995 | 372,995 | 100.00% | 14,785,522 | Mar 31, 2024 |
| VESTAL POINT CAPITAL, LP | 0.70% | 1.15% | 350,000 | 350,000 | 100.00% | 13,874,000 | Mar 31, 2024 |
| ATIKA CAPITAL MANAGEMENT LLC | 0.51% | 1.00% | 256,000 | 256,000 | 100.00% | 10,147,840 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 0.46% | 0.85% | 230,000 | 230,000 | 100.00% | 9,117,200 | Mar 31, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 0.27% | 0.42% | 133,960 | 133,960 | 100.00% | 5,310,174 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.24% | 0.00% | 121,000 | 121,000 | 100.00% | 4,796,440 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.22% | 0.01% | 110,700 | 110,700 | 100.00% | 4,388,148 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.22% | 0.00% | 109,860 | 109,860 | 100.00% | 4,354,850 | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.21% | 0.45% | 103,000 | 103,000 | 100.00% | 4,082,920 | Mar 31, 2024 |
| HANDELSBANKEN FONDER AB | 0.20% | 0.02% | 102,000 | 102,000 | 100.00% | 4,043,000 | Mar 31, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.17% | 0.32% | 85,500 | 85,500 | 100.00% | 3,389,220 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 0.16% | 0.04% | 81,578 | 81,578 | 100.00% | 3,233,752 | Mar 31, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.15% | 0.00% | 76,508 | 76,508 | 100.00% | 3,032,777 | Mar 31, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | 0.11% | 0.10% | 54,071 | 54,071 | 100.00% | 2,143,374 | Mar 31, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.10% | 0.41% | 51,714 | 51,714 | 100.00% | 2,049,943 | Mar 31, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.10% | 0.34% | 50,798 | 50,798 | 100.00% | 2,013,633 | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.10% | 0.01% | 50,729 | 50,729 | 100.00% | 2,010,898 | Mar 31, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.09% | 0.00% | 45,064 | 45,064 | 100.00% | 1,786,337 | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.06% | 0.02% | 29,900 | 29,900 | 100.00% | 1,185,236 | Mar 31, 2024 |
| CAPULA MANAGEMENT LTD | 0.05% | 0.02% | 23,970 | 23,970 | 100.00% | 950,171 | Mar 31, 2024 |
| BOSTON PARTNERS | 0.05% | 0.00% | 23,101 | 23,101 | 100.00% | 915,720 | Mar 31, 2024 |
| WEXFORD CAPITAL LP | 0.05% | 0.19% | 23,100 | 23,100 | 100.00% | 915,684 | Mar 31, 2024 |
| ATOM INVESTORS LP | 0.05% | 0.11% | 22,721 | 22,721 | 100.00% | 900,660 | Mar 31, 2024 |
| CHARTWELL INVESTMENT PARTNERS, LLC | 0.04% | 0.03% | 21,881 | 21,881 | 100.00% | 867,000 | Mar 31, 2024 |
| OPPENHEIMER & CO INC | 0.04% | 0.01% | 21,538 | 21,538 | 100.00% | 853,766 | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | 0.04% | 0.00% | 21,123 | 21,123 | 100.00% | 837,000 | Mar 31, 2024 |
| BANQUE CANTONALE VAUDOISE | 0.04% | 0.03% | 20,129 | 20,129 | 100.00% | 798,000 | Mar 31, 2024 |
| FIRST TRUST ADVISORS LP | 0.04% | 0.00% | 19,836 | 19,836 | 100.00% | 786,299 | Mar 31, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.04% | 0.00% | 18,982 | 18,982 | 100.00% | 752,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.03% | 0.00% | 16,900 | 16,900 | 100.00% | 669,916 | Mar 31, 2024 |
| OMERS ADMINISTRATION CORP | 0.03% | 0.01% | 15,400 | 15,400 | 100.00% | 610,456 | Mar 31, 2024 |
| SCIENTECH RESEARCH LLC | 0.03% | 0.31% | 14,742 | 14,742 | 100.00% | 584,373 | Mar 31, 2024 |
| BANK OF MONTREAL /CAN/ | 0.03% | 0.00% | 14,645 | 14,645 | 100.00% | 589,461 | Mar 31, 2024 |
| PROSHARE ADVISORS LLC | 0.02% | 0.00% | 11,502 | 11,502 | 100.00% | 455,940 | Mar 31, 2024 |
| E FUND MANAGEMENT CO., LTD. | 0.02% | 0.03% | 11,087 | 11,087 | 100.00% | 439,489 | Mar 31, 2024 |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 0.02% | 0.01% | 10,058 | 10,058 | 100.00% | 398,699 | Mar 31, 2024 |
| ENTROPY TECHNOLOGIES, LP | 0.02% | 0.04% | 9,688 | 9,688 | 100.00% | 384,032 | Mar 31, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.02% | 0.24% | 9,038 | 9,038 | 100.00% | 358,267 | Mar 31, 2024 |
| ARIZONA STATE RETIREMENT SYSTEM | 0.02% | 0.00% | 8,849 | 8,849 | 100.00% | 350,774 | Mar 31, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | 0.02% | 0.01% | 8,773 | 8,773 | 100.00% | 347,762 | Mar 31, 2024 |
| GTS SECURITIES LLC | 0.02% | 0.00% | 8,499 | 8,499 | 100.00% | 336,900 | Mar 31, 2024 |
| GTS SECURITIES LLC | 0.02% | 0.00% | 7,900 | 7,900 | 100.00% | 313,156 | Mar 31, 2024 |
| BELVEDERE TRADING LLC | 0.02% | 0.00% | 7,570 | 7,570 | 100.00% | 300,075 | Mar 31, 2024 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 0.01% | 0.00% | 7,165 | 7,165 | 100.00% | 284,000 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.01% | 0.00% | 6,210 | 6,210 | 100.00% | 246,000 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 5,900 | 5,900 | 100.00% | 233,876 | Mar 31, 2024 |
| HARVEST INVESTMENT SERVICES, LLC | 0.01% | 0.09% | 5,887 | 5,887 | 100.00% | 233,360 | Mar 31, 2024 |
| GLENMEDE TRUST CO NA | 0.01% | 0.00% | 5,780 | 5,780 | 100.00% | 229,119 | Mar 31, 2024 |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 0.01% | 0.02% | 5,459 | 5,459 | 100.00% | 216,395 | Mar 31, 2024 |
| BELVEDERE TRADING LLC | 0.01% | 0.00% | 5,300 | 5,300 | 100.00% | 210,092 | Mar 31, 2024 |
| US BANCORP \DE\ | 0.01% | 0.00% | 3,240 | 3,240 | 100.00% | 128,434 | Mar 31, 2024 |
| STRS OHIO | 0.00% | 0.00% | 1,900 | 1,900 | 100.00% | 75,000 | Mar 31, 2024 |
| KBC GROUP NV | 0.00% | 0.00% | 1,107 | 1,107 | 100.00% | 44,000 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | 0.00% | 1,095 | 1,095 | 100.00% | 43,406 | Mar 31, 2024 |
| ECOR1 CAPITAL, LLC | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 39,640 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.00% | - | 700 | 700 | 100.00% | 27,748 | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 691 | 691 | 100.00% | 27,391 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.00% | - | 500 | 500 | 100.00% | 19,820 | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 54 | 54 | 100.00% | 2,141,000 | Mar 31, 2024 |
| RIGGS ASSET MANAGMENT CO. INC. | - | 0.00% | 16 | 16 | 100.00% | 635 | Mar 31, 2024 |
| PRINCIPAL SECURITIES, INC. | - | - | 6 | 6 | 100.00% | 238 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 6 | 6 | 100.00% | 237 | Mar 31, 2024 |
Alpine Immune Sciences's largest new institutional shareholder by number of shares is AVORO CAPITAL ADVISORS LLC, purchased 5.78M shares, valued at $228.92M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -4,909,763 | -100.00% | - | Mar 31, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -357,271 | -100.00% | - | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -246,178 | -100.00% | - | Mar 31, 2024 |
| MARSHALL WACE, LLP | - | - | - | -221,118 | -100.00% | - | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -197,019 | -100.00% | - | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | - | - | - | -97,200 | -100.00% | - | Mar 31, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | - | - | - | -65,000 | -100.00% | - | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -55,720 | -100.00% | - | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -48,670 | -100.00% | - | Mar 31, 2024 |
| WALLEYE TRADING LLC | - | - | - | -25,596 | -100.00% | - | Mar 31, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -25,554 | -100.00% | - | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -21,878 | -100.00% | - | Mar 31, 2024 |
| CORTON CAPITAL INC. | - | - | - | -16,934 | -100.00% | - | Mar 31, 2024 |
| AJOVISTA, LLC | - | - | - | -3,371 | -100.00% | - | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -3,027 | -100.00% | - | Mar 31, 2024 |
Alpine Immune Sciences's largest sold out institutional shareholder by shares sold is RA CAPITAL MANAGEMENT, L.P., sold -4.91M shares, valued at -, as of undefined.
Alpine Immune Sciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 2.10% | 7,485 | - | - | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 1,105,737 | 237,715 | 27.39% | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 394,000 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 22,030 | - | - | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.04% | 213,300 | 213,300 | - | Dec 31, 2023 |
| BRIDGEWAY FUNDS INC | 0.03% | 67,811 | - | - | Dec 29, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,911 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 58,427 | 3,553 | 6.47% | Dec 31, 2023 |
| FORUM FUNDS II | 0.01% | 6,900 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 9,600 | 9,600 | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.01% | 2,417,479 | 1,177,717 | 95.00% | Dec 31, 2023 |
| Nushares ETF Trust | 0.00% | 34,945 | 34,945 | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 837 | 837 | - | Dec 31, 2023 |
| North Square Investments Trust | 0.00% | 34,010 | 34,010 | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 220,800 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 42,691 | 14,407 | 50.94% | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 4,347 | 4,347 | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 65,297 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 380,659 | 92,298 | 32.01% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,371 | 750 | 28.62% | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 15,879 | 5,814 | 57.76% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 208,479 | 60,797 | 41.17% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 28,788 | 5,938 | 25.99% | Dec 31, 2023 |
| ProFunds | 0.00% | 8,992 | 4,226 | 88.67% | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 2,273 | - | - | Dec 29, 2023 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 57,457 | 57,457 | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 10,211 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 172,791 | -34,478 | -16.63% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 2,010 | 2,010 | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 76,966 | 76,966 | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,053 | -449 | -3.33% | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 98,553 | 98,553 | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,724 | - | - | Dec 31, 2023 |
| Dunham Funds | 0.00% | 21,438 | 21,438 | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 725 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 181,630 | 32,065 | 21.44% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 10,800 | 1,600 | 17.39% | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 3,400 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 91,295 | 13,951 | 18.04% | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 146,282 | 20,433 | 16.24% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 290 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 7,936 | 3,229 | 68.60% | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 22,993 | 22,993 | - | Feb 29, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 1,616 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 21,793 | - | - | Jan 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 25,309 | 25,309 | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 12,496 | 265 | 2.17% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,200 | - | - | Dec 29, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 4,428 | -1,281 | -22.44% | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 9,667 | 1,876 | 24.08% | Feb 29, 2024 |
| GPS Funds I | 0.00% | 180 | - | - | Dec 31, 2023 |
| RYDEX DYNAMIC FUNDS | 0.00% | 144 | - | - | Dec 31, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 3,800 | 100 | 2.70% | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,420 | 261 | 8.26% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,939 | 1,939 | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 715,192 | 715,192 | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund II | 0.00% | 16,400 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 53,407 | 35,153 | 192.58% | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 37,186 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 19 | - | - | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 14,250 | -297 | -2.04% | Dec 29, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 15,824 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 69 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,084 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,689 | 78 | 2.16% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 589 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 438 | 438 | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 16,728 | -1,105 | -6.20% | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 10,697 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 4,066 | 685 | 20.26% | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 11,584 | -389 | -3.25% | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 49,788 | -1,522,954 | -96.83% | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 1,000 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 176 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 11,941 | 11,898 | 27669.77% | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 9,924 | 1,487 | 17.62% | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,171 | - | - | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 13,700 | 9,300 | 211.36% | Feb 29, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 4,100 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 17,907 | -13,021 | -42.10% | Feb 29, 2024 |
Alpine Immune Sciences's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 7.49K shares, compromising 2.10% of its total assets.
Alpine Immune Sciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 84 | -37.31% |
| 31 Dec, 23 | 134 | 50.56% |
| 30 Sep, 23 | 89 | 17.11% |
| 30 Jun, 23 | 76 | 31.03% |
| 31 Mar, 23 | 58 | -7.94% |
| 31 Dec, 22 | 63 | -5.97% |
| 30 Sep, 22 | 67 | 19.64% |
| 30 Jun, 22 | 56 | 1.82% |
| 31 Mar, 22 | 55 | 3.77% |
| 31 Dec, 21 | 53 | 20.45% |
| 30 Sep, 21 | 44 | -6.38% |
| 30 Jun, 21 | 47 | 2.17% |
| 31 Mar, 21 | 46 | 6.98% |
| 31 Dec, 20 | 43 | 26.47% |
| 30 Sep, 20 | 34 | 78.95% |
| 30 Jun, 20 | 19 | 26.67% |
| 31 Mar, 20 | 15 | -21.05% |
| 31 Dec, 19 | 19 | 5.56% |
| 30 Sep, 19 | 18 | -21.74% |
| 30 Jun, 19 | 23 | - |
| 31 Mar, 19 | 23 | - |
| 31 Dec, 18 | 23 | 4.55% |
| 30 Sep, 18 | 22 | -4.35% |
| 30 Jun, 18 | 23 | -17.86% |
| 31 Mar, 18 | 28 | 3.70% |
| 31 Dec, 17 | 27 | 17.39% |
| 30 Sep, 17 | 23 | - |
As of 31 Mar 24, 84 institutions are holding Alpine Immune Sciences's shares, representing a decrease of -37.31% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 14,158,217 | -75.97% |
| 31 Dec, 23 | 58,910,405 | 28.28% |
| 30 Sep, 23 | 45,924,841 | 24.18% |
| 30 Jun, 23 | 36,983,656 | 6.71% |
| 31 Mar, 23 | 34,658,119 | 1.36% |
| 31 Dec, 22 | 34,192,464 | -13.32% |
| 30 Sep, 22 | 39,444,842 | 64.34% |
| 30 Jun, 22 | 24,002,617 | -2.90% |
| 31 Mar, 22 | 24,719,823 | 33.13% |
| 31 Dec, 21 | 18,568,512 | 21.13% |
| 30 Sep, 21 | 15,328,864 | 16.41% |
| 30 Jun, 21 | 13,168,360 | -3.47% |
| 31 Mar, 21 | 13,642,024 | 3.70% |
| 31 Dec, 20 | 13,155,520 | 4.57% |
| 30 Sep, 20 | 12,581,030 | 76.62% |
| 30 Jun, 20 | 7,123,051 | -12.60% |
| 31 Mar, 20 | 8,150,322 | -3.24% |
| 31 Dec, 19 | 8,422,947 | -3.14% |
| 30 Sep, 19 | 8,696,034 | -0.18% |
| 30 Jun, 19 | 8,711,770 | -0.27% |
| 31 Mar, 19 | 8,735,247 | 17.24% |
| 31 Dec, 18 | 7,450,493 | -1.65% |
| 30 Sep, 18 | 7,575,873 | -3.75% |
| 30 Jun, 18 | 7,870,836 | -0.13% |
| 31 Mar, 18 | 7,881,320 | -0.71% |
| 31 Dec, 17 | 7,937,910 | 1.11% |
| 30 Sep, 17 | 7,851,039 | - |
Alpine Immune Sciences (ALPN) has 14.16M shares outstanding as of 31 Mar 24, down -75.97% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 28.32% | 0.20% |
| 31 Dec, 23 | 119.68% | 1.31% |
| 30 Sep, 23 | 95.58% | 1.58% |
| 30 Jun, 23 | 77.75% | 1.46% |
| 31 Mar, 23 | 72.86% | 0.70% |
| 31 Dec, 22 | 102.26% | 0.66% |
| 30 Sep, 22 | 124.93% | 1.99% |
| 30 Jun, 22 | 79.15% | 1.19% |
| 31 Mar, 22 | 81.67% | 1.54% |
| 31 Dec, 21 | 72.88% | 1.90% |
| 30 Sep, 21 | 62.00% | 2.04% |
| 30 Jun, 21 | 55.08% | 1.69% |
| 31 Mar, 21 | 57.15% | 1.43% |
| 31 Dec, 20 | 63.17% | 1.98% |
| 30 Sep, 20 | 56.48% | 3.85% |
| 30 Jun, 20 | 38.32% | 1.99% |
| 31 Mar, 20 | 43.85% | 2.14% |
| 31 Dec, 19 | 45.31% | 2.07% |
| 30 Sep, 19 | 46.79% | 2.13% |
| 30 Jun, 19 | 46.90% | 1.92% |
| 31 Mar, 19 | 49.43% | 1.71% |
| 31 Dec, 18 | 53.80% | 1.80% |
| 30 Sep, 18 | 54.69% | 1.69% |
| 30 Jun, 18 | 56.83% | 1.75% |
| 31 Mar, 18 | 56.93% | 1.73% |
| 31 Dec, 17 | 57.34% | 1.04% |
| 30 Sep, 17 | 74.22% | - |
As of 31 Mar 24, Alpine Immune Sciences is held by 28.32% institutional shareholders, representing a 0.20% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 66 | -43.10% |
| 31 Dec, 23 | 116 | 127.45% |
| 30 Sep, 23 | 51 | -1.92% |
| 30 Jun, 23 | 52 | 67.74% |
| 31 Mar, 23 | 31 | -22.50% |
| 31 Dec, 22 | 40 | 5.26% |
| 30 Sep, 22 | 38 | 31.03% |
| 30 Jun, 22 | 29 | 16.00% |
| 31 Mar, 22 | 25 | -26.47% |
| 31 Dec, 21 | 34 | 54.55% |
| 30 Sep, 21 | 22 | -4.35% |
| 30 Jun, 21 | 23 | -4.17% |
| 31 Mar, 21 | 24 | - |
| 31 Dec, 20 | 24 | -11.11% |
| 30 Sep, 20 | 27 | 125.00% |
| 30 Jun, 20 | 12 | 500.00% |
| 31 Mar, 20 | 2 | -33.33% |
| 31 Dec, 19 | 3 | -50.00% |
| 30 Sep, 19 | 6 | -25.00% |
| 30 Jun, 19 | 8 | -20.00% |
| 31 Mar, 19 | 10 | 66.67% |
| 31 Dec, 18 | 6 | -25.00% |
| 30 Sep, 18 | 8 | -20.00% |
| 30 Jun, 18 | 10 | - |
| 31 Mar, 18 | 10 | -23.08% |
| 31 Dec, 17 | 13 | -43.48% |
| 30 Sep, 17 | 23 | - |
66 institutional shareholders have increased their position in ALPN stock as of 31 Mar 24 compared to 116 in the previous quarter (a -43.10% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 13 | 30.00% |
| 31 Dec, 23 | 10 | -52.38% |
| 30 Sep, 23 | 21 | 75.00% |
| 30 Jun, 23 | 12 | - |
| 31 Mar, 23 | 12 | 33.33% |
| 31 Dec, 22 | 9 | -47.06% |
| 30 Sep, 22 | 17 | - |
| 30 Jun, 22 | 17 | - |
| 31 Mar, 22 | 17 | 88.89% |
| 31 Dec, 21 | 9 | -30.77% |
| 30 Sep, 21 | 13 | -7.14% |
| 30 Jun, 21 | 14 | 40.00% |
| 31 Mar, 21 | 10 | 42.86% |
| 31 Dec, 20 | 7 | 133.33% |
| 30 Sep, 20 | 3 | 50.00% |
| 30 Jun, 20 | 2 | -33.33% |
| 31 Mar, 20 | 3 | -57.14% |
| 31 Dec, 19 | 7 | 40.00% |
| 30 Sep, 19 | 5 | -28.57% |
| 30 Jun, 19 | 7 | -12.50% |
| 31 Mar, 19 | 8 | 14.29% |
| 31 Dec, 18 | 7 | 16.67% |
| 30 Sep, 18 | 6 | 50.00% |
| 30 Jun, 18 | 4 | -20.00% |
| 31 Mar, 18 | 5 | - |
| 31 Dec, 17 | 5 | - |
| 30 Sep, 17 | - | - |
13 institutional shareholders have reduced their position in ALPN stock as of 31 Mar 24 compared to 10 in the previous quarter (a 30.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 84 | -37.31% | 14,158,217 | -75.97% | 28.32% | 0.20% | 66 | -43.10% | 13 | 30.00% |
| 31 Dec, 23 | 134 | 50.56% | 58,910,405 | 28.28% | 119.68% | 1.31% | 116 | 127.45% | 10 | -52.38% |
| 30 Sep, 23 | 89 | 17.11% | 45,924,841 | 24.18% | 95.58% | 1.58% | 51 | -1.92% | 21 | 75.00% |
| 30 Jun, 23 | 76 | 31.03% | 36,983,656 | 6.71% | 77.75% | 1.46% | 52 | 67.74% | 12 | - |
| 31 Mar, 23 | 58 | -7.94% | 34,658,119 | 1.36% | 72.86% | 0.70% | 31 | -22.50% | 12 | 33.33% |
| 31 Dec, 22 | 63 | -5.97% | 34,192,464 | -13.32% | 102.26% | 0.66% | 40 | 5.26% | 9 | -47.06% |
| 30 Sep, 22 | 67 | 19.64% | 39,444,842 | 64.34% | 124.93% | 1.99% | 38 | 31.03% | 17 | - |
| 30 Jun, 22 | 56 | 1.82% | 24,002,617 | -2.90% | 79.15% | 1.19% | 29 | 16.00% | 17 | - |
| 31 Mar, 22 | 55 | 3.77% | 24,719,823 | 33.13% | 81.67% | 1.54% | 25 | -26.47% | 17 | 88.89% |
| 31 Dec, 21 | 53 | 20.45% | 18,568,512 | 21.13% | 72.88% | 1.90% | 34 | 54.55% | 9 | -30.77% |
| 30 Sep, 21 | 44 | -6.38% | 15,328,864 | 16.41% | 62.00% | 2.04% | 22 | -4.35% | 13 | -7.14% |
| 30 Jun, 21 | 47 | 2.17% | 13,168,360 | -3.47% | 55.08% | 1.69% | 23 | -4.17% | 14 | 40.00% |
| 31 Mar, 21 | 46 | 6.98% | 13,642,024 | 3.70% | 57.15% | 1.43% | 24 | - | 10 | 42.86% |
| 31 Dec, 20 | 43 | 26.47% | 13,155,520 | 4.57% | 63.17% | 1.98% | 24 | -11.11% | 7 | 133.33% |
| 30 Sep, 20 | 34 | 78.95% | 12,581,030 | 76.62% | 56.48% | 3.85% | 27 | 125.00% | 3 | 50.00% |
| 30 Jun, 20 | 19 | 26.67% | 7,123,051 | -12.60% | 38.32% | 1.99% | 12 | 500.00% | 2 | -33.33% |
| 31 Mar, 20 | 15 | -21.05% | 8,150,322 | -3.24% | 43.85% | 2.14% | 2 | -33.33% | 3 | -57.14% |
| 31 Dec, 19 | 19 | 5.56% | 8,422,947 | -3.14% | 45.31% | 2.07% | 3 | -50.00% | 7 | 40.00% |
| 30 Sep, 19 | 18 | -21.74% | 8,696,034 | -0.18% | 46.79% | 2.13% | 6 | -25.00% | 5 | -28.57% |
| 30 Jun, 19 | 23 | - | 8,711,770 | -0.27% | 46.90% | 1.92% | 8 | -20.00% | 7 | -12.50% |
| 31 Mar, 19 | 23 | - | 8,735,247 | 17.24% | 49.43% | 1.71% | 10 | 66.67% | 8 | 14.29% |
| 31 Dec, 18 | 23 | 4.55% | 7,450,493 | -1.65% | 53.80% | 1.80% | 6 | -25.00% | 7 | 16.67% |
| 30 Sep, 18 | 22 | -4.35% | 7,575,873 | -3.75% | 54.69% | 1.69% | 8 | -20.00% | 6 | 50.00% |
| 30 Jun, 18 | 23 | -17.86% | 7,870,836 | -0.13% | 56.83% | 1.75% | 10 | - | 4 | -20.00% |
| 31 Mar, 18 | 28 | 3.70% | 7,881,320 | -0.71% | 56.93% | 1.73% | 10 | -23.08% | 5 | - |
| 31 Dec, 17 | 27 | 17.39% | 7,937,910 | 1.11% | 57.34% | 1.04% | 13 | -43.48% | 5 | - |
| 30 Sep, 17 | 23 | - | 7,851,039 | - | 74.22% | - | 23 | - | - | - |
Alpine Immune Sciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Alpine Immune Sciences's stock was made by PENG STANFORD L on May 10 2024, selling 13,377 shares at $6.33 per share (valued at $84.68K).
Alpine Immune Sciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 21 | 25 | 84.00% |
| Q1 2024 | 22 | 10 | 220.00% |
| Q4 2023 | 21 | 48 | 43.75% |
| Q2 2023 | - | 8 | - |
| Q1 2023 | 11 | - | - |
| Q3 2022 | 7 | 1 | 700.00% |
| Q1 2022 | 11 | - | - |
| Q4 2021 | - | 1 | - |
| Q3 2021 | 12 | 7 | 171.43% |
| Q2 2021 | 1 | 8 | 12.50% |
| Q1 2021 | 12 | 7 | 171.43% |
| Q4 2020 | 4 | 8 | 50.00% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | - | 3 | - |
| Q1 2020 | 13 | - | - |
| Q4 2019 | - | 2 | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | 28 | 1 | 2800.00% |
| Q3 2018 | 2 | - | - |
| Q2 2018 | 1 | 3 | 33.33% |
21 total buy trades, and 25 total sell trades (buy/sell ratio of 0.84%) were made by Alpine Immune Sciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | 2 | 29 | 6.90% |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | - | - | - |
| Q1 2022 | 1 | - | - |
| Q4 2021 | - | 1 | - |
| Q3 2021 | 9 | 8 | 112.50% |
| Q2 2021 | - | 8 | - |
| Q1 2021 | - | 5 | - |
| Q4 2020 | 1 | 2 | 50.00% |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | 14 | 1 | 1400.00% |
| Q3 2018 | - | - | - |
| Q2 2018 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Alpine Immune Sciences's stocks.
Alpine Immune Sciences Peer Ownership
| Ticker | Company |
|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| ANAB | AnaptysBio, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| MLTX | MoonLake Immunotherapeutics |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| DAWN | Day One Biopharmaceuticals, Inc. |
| TNYA | Tenaya Therapeutics, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| IGMS | IGM Biosciences, Inc. |
| ADAG | Adagene Inc. |
| BCYC | Bicycle Therapeutics plc |
ALPN Ownership FAQ
Who Owns Alpine Immune Sciences?
Alpine Immune Sciences is owned by institutional shareholders (28.32%), insiders (4.65%), and public (67.03%). The largest institutional shareholder of Alpine Immune Sciences is DECHENG CAPITAL LLC (16.64% of total shares) and the top mutual fund owner is SPARROW FUNDS (2.10% of total shares).
Who are the major institutional shareholders of Alpine Immune Sciences?
Alpine Immune Sciences's major institutional shareholders are DECHENG CAPITAL LLC, AVORO CAPITAL ADVISORS LLC, BLACKROCK INC., FRAZIER LIFE SCIENCES MANAGEMENT, L.P., and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 47.76% of the company's share outstanding.
How many Alpine Immune Sciences shareholders are there?
As of Mar 2024, there are 84 institutional shareholders of Alpine Immune Sciences.
What percentage of Alpine Immune Sciences is owned by DECHENG CAPITAL LLC?
DECHENG CAPITAL LLC owns 8.32M shares of Alpine Immune Sciences, representing 16.64% of the company's total shares outstanding, valued at $329.72M (as of Mar 2024).
What percentage of Alpine Immune Sciences is owned by AVORO CAPITAL ADVISORS LLC?
As of Mar 2024, AVORO CAPITAL ADVISORS LLC holds 5.78M shares of Alpine Immune Sciences (ALPN), compromising 11.55% of the company, valued at $228.92M.
What percentage of Alpine Immune Sciences is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Alpine Immune Sciences. The company owns 3.58M of the company's shares outstanding (worth $141.72M).